ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Active Pharmaceutical Ingredient (API)	408.73M	154.78M	119.41M				64.43M	104.37M
Active Pharmaceutical Ingredient (API) Growth	164.07%	29.62%	-				-38.27%	26.41%
Preparations	196.61M	189.37M	176.71M				190.40M	128.82M
Preparations Growth	3.82%	7.17%	-				47.80%	120.44%
Pharmaceutical Research Services	89.68M	60.92M	92.33M				36.84M	23.75M
Pharmaceutical Research Services Growth	47.22%	-34.02%	-				55.14%	-29.27%
Customized Production	23.33M	26.24M	11.09M				20.44M	10.65M
Customized Production Growth	-11.10%	136.68%	-				92.01%	-36.63%
Technology Transfer	16.98M	-	-				-	-
Consignment Processing Services	45.45K	19.78M	31.79M				13.22M	6.95M
Consignment Processing Services Growth	-99.77%	-37.79%	-				90.16%	270.13%
Unallocated Others	5.59M	4.78M	3.70M				-	-
Unallocated Others Growth	17.08%	29.15%	-				-	-
Total	740.96M	455.86M	435.02M				325.33M	274.54M
Total Growth	62.54%	4.79%	-				18.50%	42.06%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	341.90M	307.54M	349.75M				297.49M	197.06M
China Growth	11.17%	-12.07%	-				50.96%	39.51%
Overseas	399.07M	148.32M	85.27M				27.85M	77.48M
Overseas Growth	169.06%	73.93%	-				-64.06%	48.98%
Total	740.96M	455.86M	435.02M				325.33M	274.54M
Total Growth	62.54%	4.79%	-				18.50%	42.06%

Source: S&P Global Market Intelligence.